Turkish Version of Back Pain Knowledge and Beliefs Survey (BacKS-tr)

Validity, Reliability, and Cross-Cultural Adaptation of the Turkish Version of Back Pain Knowledge and Beliefs Survey (BacKS)

Low back pain (LBP) is a globally prevalent health issue, affecting the majority of individuals at some point in their lives. Misconceptions about LBP can prolong its chronicity, highlighting the importance of educating patients with accurate information. The Back Pain Knowledge and Beliefs Survey (BacKS), introduced in 2024, aims to measure individuals' knowledge about LBP based on updated scientific evidence. Given the high prevalence of LBP in Turkey and the lack of validated tools in Turkish, adapting BacKS to Turkish is essential. This study aims to conduct its cross-cultural adaptation, validation, and reliability analysis for clinical and community use.

Study Overview

• Status: Active, not recruiting
• Conditions: Back Pain; Knowledge; Beliefs; Translation, Cultural Adaptation and Turkish Validation
• Intervention / Treatment: Other: Backs-tr retest; Other: The Back Belief Questionnaire Tr (BBQ) and Backs-tr

Detailed Description

Low back pain (LBP) is one of the most prevalent health issues worldwide, with approximately three-quarters of individuals experiencing this condition at some point in their lives. Misconceptions, beliefs, and misinformation about LBP can prolong the duration of pain and contribute to its chronicity. Clinical guidelines emphasize the importance of educating patients with evidence-based information to remove potential barriers to recovery.

The Back Pain Knowledge and Beliefs Survey (BacKS) was introduced in October 2024 to assess individuals' knowledge and beliefs about LBP based on the most recent scientific evidence. Several tools in the literature aim to measure knowledge and beliefs related to LBP, including the Back Beliefs Questionnaire (BBQ) and the Back Pain Knowledge Questionnaire. However, these tools were developed in previous decades and may not reflect the current scientific literature. Additionally, the Turkish versions of some of these questionnaires have not yet undergone validation and reliability studies.

According to the 2016-2022 Turkish Health Survey conducted by the Turkish Statistical Institute (TÜİK), back-related problems rank first among all reported health issues, with a prevalence rate of 24.6%. Despite the high prevalence of LBP in Turkey, there is currently no systematically validated tool available in Turkish to measure the public's knowledge and beliefs regarding this condition.

The adaptation of BacKS into Turkish will help address this gap by providing a valid and reliable tool for both clinical and community-based research. Measuring and evaluating patient-reported outcomes accurately is crucial in managing LBP effectively. Therefore, the aim of this study is to conduct the cross-cultural adaptation, validation, and reliability analysis of the Turkish version of BacKS.

• Study Type: Observational
• Enrollment (Estimated): 200

Contacts and Locations

Study Locations

• Turkey
  • Altinordu
    • Ordu, Altinordu, Turkey, 52200
      • Ordu University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Probability Sample

Study Population

Individuals with current low back pain or a history of low back pain in the last 12 months.

Description

Inclusion Criteria:

• Having low back pain or having a history of low back pain in the last 12 months
• To be able to read and write Turkish

Exclusion Criteria:

• Having cognitive impairment that prevents communication
• Pregnancy
• Malignite
• Infections
• Fractures,
• Inflammatory diseases

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Test-retest group; One hundred of the participants who were administered the Tr-BacKS will fill out the same form again after 1 week.	Other: Backs-tr retest; 100 people will fill in the Backs-tr again after 1 week.
Test group; The questionnaire will be administered once to these 100 participants	Other: The Back Belief Questionnaire Tr (BBQ) and Backs-tr; 200 people will be administered The Back Belief Questionnaire Tr (BBQ) and Backs-tr.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Validation	200 people will be compared with the scores obtained from the Backs-Tr questionnaire	15.01.2025- 15.04.2025
The Back Belief Questionnaire (BBQ).	200 people will be compared with the scores obtained from The Back Belief Questionnaire (BBQ).	15.01.2025- 15.04.2025

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Reliability	One hundred of the participants who were administered the Tr-BacKS will fill out the same form again after 1 week. The two measurement scores obtained from the participants will be compared using the Intraclass Correlation Coefficient (ICC).	15.01.2025- 15.04.2025
Internal Consistency Reliability	Internal consistency will be assessed separately for the biomedical (9 items) and self-care factor (11 items) in the original questionnaire. Internal consistency reliability will also be assessed for all items. Cronbach's Alpha will be used in the evaluation.	15.01.2025- 15.04.2025

Collaborators and Investigators

• Sponsor: T.C. ORDU ÜNİVERSİTESİ
• Collaborators: Macquarie University, Australia

Study record dates

Study Major Dates

• Study Start (Actual): November 15, 2024
• Primary Completion (Estimated): November 15, 2025
• Study Completion (Estimated): December 15, 2025

Study Registration Dates

• First Submitted: January 6, 2025
• First Submitted That Met QC Criteria: January 16, 2025
• First Posted (Actual): January 17, 2025

Study Record Updates

• Last Update Posted (Estimated): August 15, 2025
• Last Update Submitted That Met QC Criteria: August 14, 2025
• Last Verified: August 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Back Pain
• Other Study ID Numbers: E-14647249-000-1075264

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No